ATLASBlossomHill Therapeutics (BLSM) earnings date: Dec 18, 2026
BlossomHill Therapeutics (BLSM) reports earnings for the quarter ended Sep 30, 2026 on Fri, Dec 18, 2026. Analysts expect EPS of -$0.93.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on BLSM
| Last price | $13.75 (-9.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.6% |
These figures come from the same calibrated model and valuation as the BlossomHill Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
BlossomHill Therapeutics reports on Dec 18, 2026. One email the day before, with ATLAS’s read on BlossomHill Therapeutics. You can switch it off at any time.
Alert me before BLSM reportsFree to start. Creating an account takes under a minute.
BLSM earnings at a glance
| Next report (confirmed) | Fri, Dec 18, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.93 |
| Last report | Sep 18, 2026 · Miss |
| Average EPS surprise | -941.7% |
| Sector | Healthcare · Biotechnology |
BlossomHill Therapeutics earnings history: last 1 reports
BlossomHill Therapeutics last reported on Sep 18, 2026: EPS of -$8.75 against an estimate of -$0.84 (-941.7% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Sep 18, 2026 | -$0.84 | -$8.75 | -941.7% | Miss | -0.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for BLSM
See the fair value, the probability range and the earnings history of BlossomHill Therapeutics on its ATLAS page.
BlossomHill Therapeutics (BLSM) stock analysisPlans from €3.99 a month.
BlossomHill Therapeutics earnings: frequently asked questions
When does BlossomHill Therapeutics (BLSM) report earnings?
BlossomHill Therapeutics is scheduled to report on Friday, December 18, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for BLSM?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.93 per share (USD). Estimates can change before the report.
Did BlossomHill Therapeutics beat earnings estimates last quarter?
BlossomHill Therapeutics last reported on Sep 18, 2026: EPS of -$8.75 against an estimate of -$0.84 (-941.7% surprise), a miss.
How much does BLSM usually move in a day?
On a normal trading day the ATLAS model puts BLSM’s one-day range at about ±4.6%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Dec 18, 2026
Educational information, not investment advice. Disclaimer